Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 207

1.

Systematic review with meta-analysis: mortality in acute severe ulcerative colitis.

Dong C, Metzger M, Holsbø E, Perduca V, Carbonnel F.

Aliment Pharmacol Ther. 2019 Dec 10. doi: 10.1111/apt.15592. [Epub ahead of print] Review.

PMID:
31821584
2.

Complementary and Alternative Medicine in Patients With Breast Cancer: Exploratory Study of Social Network Forum Data.

Lognos B, Carbonnel F, Boulze Launay I, Bringay S, Guerdoux-Ninot E, Mollevi C, Senesse P, Ninot G.

JMIR Cancer. 2019 Nov 27;5(2):e12536. doi: 10.2196/12536.

3.

Real-world evidence of tofacitinib effectiveness and safety in patients with refractory ulcerative colitis.

Lair-Mehiri L, Stefanescu C, Vaysse T, Laharie D, Roblin X, Rosa I, Treton X, Abitbol V, Amiot A, Bouguen G, Dib N, Fumery M, Pariente B, Carbonnel F, Peyrin-Biroulet L, Simon M, Viennot S, Bouhnik Y.

Dig Liver Dis. 2019 Nov 12. pii: S1590-8658(19)30844-8. doi: 10.1016/j.dld.2019.10.003. [Epub ahead of print]

PMID:
31732444
4.

Identifying Frameworks for Validation and Monitoring of Consensual Behavioral Intervention Technologies: Narrative Review.

Carbonnel F, Ninot G.

J Med Internet Res. 2019 Oct 16;21(10):e13606. doi: 10.2196/13606. Review.

5.

Interstitial and Granulomatous lung disease in inflammatory bowel disease patients.

Eliadou E, Moleiro J, Ribaldone DG, Astegiano M, Rothfuss K, Taxonera C, Ghalim F, Carbonnel F, Verstockt B, Festa S, Maia L, Berrozpe A, Zagorowicz E, Savarino E, Ellul P, Vavricka SR, Calvo M, Koutroubakis I, Hoentjen F, Luis FS, Callela F, Cañete Pizarro F, Soufleris K, Sonnenberg E, Cavicchi M, Wypych J, Hommel C, Ghiani A, Fiorino G; ECCO CONFER COMMITTEE.

J Crohns Colitis. 2019 Oct 11. pii: jjz165. doi: 10.1093/ecco-jcc/jjz165. [Epub ahead of print]

PMID:
31602473
6.

Antibody Responses to Fusobacterium nucleatum Proteins in Prediagnostic Blood Samples are not Associated with Risk of Developing Colorectal Cancer.

Butt J, Jenab M, Pawlita M, Overvad K, Tjonneland A, Olsen A, Boutron-Ruault MC, Carbonnel F, Mancini FR, Kaaks R, Kühn T, Boeing H, Trichopoulou A, Karakatsani A, Palli D, Pala VM, Tumino R, Sacerdote C, Panico S, Bueno-de-Mesquita B, van Gils CH, Vermeulen RCH, Weiderpass E, Quirós JR, Duell EJ, Sánchez MJ, Dorronsoro M, Huerta JM, Ardanaz E, Van Guelpen B, Harlid S, Perez-Cornago A, Gunter MJ, Murphy N, Freisling H, Aune D, Waterboer T, Hughes DJ.

Cancer Epidemiol Biomarkers Prev. 2019 Sep;28(9):1552-1555. doi: 10.1158/1055-9965.EPI-19-0313.

PMID:
31481495
7.

[The Childhood Asthma Control Test improves the therapeutic adaptations recommended for asthmatics aged 6 to 11 years in primary practice. A Randomized comparative prospective study].

Perron G, Garcia M, Carbonnel F, Trebuchon F, Daures JP, Amouyal M, Demoly P, Costa D.

Presse Med. 2019 Sep;48(9):e257-e266. doi: 10.1016/j.lpm.2018.10.021. Epub 2019 Aug 28. French.

PMID:
31473028
8.

Vitamin D-Related Genes, Blood Vitamin D Levels and Colorectal Cancer Risk in Western European Populations.

Fedirko V, Mandle HB, Zhu W, Hughes DJ, Siddiq A, Ferrari P, Romieu I, Riboli E, Bueno-de-Mesquita B, van Duijnhoven FJB, Siersema PD, Tjønneland A, Olsen A, Perduca V, Carbonnel F, Boutron-Ruault MC, Kühn T, Johnson T, Krasimira A, Trichopoulou A, Makrythanasis P, Thanos D, Panico S, Krogh V, Sacerdote C, Skeie G, Weiderpass E, Colorado-Yohar S, Sala N, Barricarte A, Sanchez MJ, Quirós R, Amiano P, Gylling B, Harlid S, Perez-Cornago A, Heath AK, Tsilidis KK, Aune D, Freisling H, Murphy N, Gunter MJ, Jenab M.

Nutrients. 2019 Aug 20;11(8). pii: E1954. doi: 10.3390/nu11081954.

9.

Baseline gut microbiota predicts clinical response and colitis in metastatic melanoma patients treated with ipilimumab.

Chaput N, Lepage P, Coutzac C, Soularue E, Le Roux K, Monot C, Boselli L, Routier E, Cassard L, Collins M, Vaysse T, Marthey L, Eggermont A, Asvatourian V, Lanoy E, Mateus C, Robert C, Carbonnel F.

Ann Oncol. 2019 Aug 13. pii: mdz224. doi: 10.1093/annonc/mdz224. [Epub ahead of print] No abstract available.

PMID:
31408090
10.

The effectiveness and safety of infliximab compared with biosimilar CT-P13, in 3112 patients with ulcerative colitis.

Meyer A, Rudant J, Drouin J, Coste J, Carbonnel F, Weill A.

Aliment Pharmacol Ther. 2019 Aug;50(3):269-277. doi: 10.1111/apt.15323. Epub 2019 May 22.

11.

Vedolizumab Therapy is Ineffective for Primary Sclerosing Cholangitis in Patients With Inflammatory Bowel Disease: A GETAID Multicentre Cohort Study.

Caron B, Peyrin-Biroulet L, Pariente B, Bouhnik Y, Seksik P, Bouguen G, Caillo L, Laharie D, Carbonnel F, Altwegg R, Reenaers C, Serrero M, Trang-Poisson C, Nancey S, Filippi J, Abitbol V, Savoye G, Vuitton L, Viennot S, Fumery M, Reymond M, Bronowicki JP, Reimund JM, Amiot A.

J Crohns Colitis. 2019 Sep 27;13(10):1239-1247. doi: 10.1093/ecco-jcc/jjz088.

PMID:
31056693
12.

Anthropometric and reproductive factors and risk of esophageal and gastric cancer by subtype and subsite: Results from the European Prospective Investigation into Cancer and Nutrition (EPIC) cohort.

Sanikini H, Muller DC, Sophiea M, Rinaldi S, Agudo A, Duell EJ, Weiderpass E, Overvad K, Tjønneland A, Halkjaer J, Boutron-Ruault MC, Carbonnel F, Cervenka I, Boeing H, Kaaks R, Kühn T, Trichopoulou A, Martimianaki G, Karakatsani A, Pala V, Palli D, Mattiello A, Tumino R, Sacerdote C, Skeie G, Rylander C, Chirlaque López MD, Sánchez MJ, Ardanaz E, Regnér S, Stocks T, Bueno-de-Mesquita B, Vermeulen RCH, Aune D, Tong TYN, Kliemann N, Murphy N, Chadeau-Hyam M, Gunter MJ, Cross AJ.

Int J Cancer. 2019 May 3. doi: 10.1002/ijc.32386. [Epub ahead of print]

13.

Gallstones and incident colorectal cancer in a large pan-European cohort study.

Ward HA, Murphy N, Weiderpass E, Leitzmann MF, Aglago E, Gunter MJ, Freisling H, Jenab M, Boutron-Ruault MC, Severi G, Carbonnel F, Kühn T, Kaaks R, Boeing H, Tjønneland A, Olsen A, Overvad K, Merino S, Zamora-Ros R, Rodríguez-Barranco M, Dorronsoro M, Chirlaque MD, Barricarte A, Perez-Cornago A, Trichopoulou A, Bamia C, Lagiou P, Masala G, Grioni S, Tumino R, Sacerdote C, Mattiello A, Bueno-de-Mesquita B, Vermeulen R, Van Gils C, Nyström H, Rutegård M, Aune D, Riboli E, Cross AJ.

Int J Cancer. 2019 Sep 15;145(6):1510-1516. doi: 10.1002/ijc.32090. Epub 2019 Jan 11.

PMID:
30585640
14.

Association between physical activity and risk of hepatobiliary cancers: A multinational cohort study.

Baumeister SE, Schlesinger S, Aleksandrova K, Jochem C, Jenab M, Gunter MJ, Overvad K, Tjønneland A, Boutron-Ruault MC, Carbonnel F, Fournier A, Kühn T, Kaaks R, Pischon T, Boeing H, Trichopoulou A, Bamia C, La Vecchia C, Masala G, Panico S, Fasanelli F, Tumino R, Grioni S, Bueno de Mesquita B, Vermeulen R, May AM, Borch KB, Oyeyemi SO, Ardanaz E, Rodríguez-Barranco M, Dolores Chirlaque López M, Felez-Nobrega M, Sonestedt E, Ohlsson B, Hemmingsson O, Werner M, Perez-Cornago A, Ferrari P, Stepien M, Freisling H, Tsilidis KK, Ward H, Riboli E, Weiderpass E, Leitzmann MF.

J Hepatol. 2019 May;70(5):885-892. doi: 10.1016/j.jhep.2018.12.014. Epub 2018 Dec 22.

15.

Effectiveness and Safety of Reference Infliximab and Biosimilar in Crohn Disease: A French Equivalence Study.

Meyer A, Rudant J, Drouin J, Weill A, Carbonnel F, Coste J.

Ann Intern Med. 2019 Jan 15;170(2):99-107. doi: 10.7326/M18-1512. Epub 2018 Dec 11.

PMID:
30534946
16.

Evolution and recurrence of gastrointestinal immune-related adverse events induced by immune checkpoint inhibitors.

de Malet A, Antoni G, Collins M, Soularue E, Marthey L, Vaysse T, Coutzac C, Chaput N, Mateus C, Robert C, Carbonnel F.

Eur J Cancer. 2019 Jan;106:106-114. doi: 10.1016/j.ejca.2018.10.006. Epub 2018 Nov 23.

PMID:
30476730
17.

Networks meet ulcerative colitis.

Carbonnel F.

Lancet Gastroenterol Hepatol. 2018 Nov;3(11):730-731. doi: 10.1016/S2468-1253(18)30283-8. No abstract available.

PMID:
30353851
18.

Towards more efficient assessment of ulcerative colitis drugs.

Carbonnel F.

Lancet Gastroenterol Hepatol. 2019 Jan;4(1):8-9. doi: 10.1016/S2468-1253(18)30342-X. Epub 2018 Oct 18. No abstract available.

PMID:
30343115
19.

Efficacy and Safety of Induction Therapy With Calcineurin Inhibitors in Combination With Vedolizumab in Patients With Refractory Ulcerative Colitis.

Pellet G, Stefanescu C, Carbonnel F, Peyrin-Biroulet L, Roblin X, Allimant C, Nachury M, Nancey S, Filippi J, Altwegg R, Brixi H, Fotsing G, de Rosamel L, Shili S, Laharie D; Groupe d'Etude Thérapeutique des Affections Inflammatoires du tube Digestif.

Clin Gastroenterol Hepatol. 2019 Feb;17(3):494-501. doi: 10.1016/j.cgh.2018.08.081. Epub 2018 Sep 10.

PMID:
30213584
20.

Somatostatin analogues for refractory diarrhoea in familial amyloid polyneuropathy.

Collins M, Pellat A, Antoni G, Agostini H, Labeyrie C, Adams D, Carbonnel F.

PLoS One. 2018 Aug 30;13(8):e0201869. doi: 10.1371/journal.pone.0201869. eCollection 2018.

21.

Enterocolitis due to immune checkpoint inhibitors: a systematic review.

Soularue E, Lepage P, Colombel JF, Coutzac C, Faleck D, Marthey L, Collins M, Chaput N, Robert C, Carbonnel F.

Gut. 2018 Nov;67(11):2056-2067. doi: 10.1136/gutjnl-2018-316948. Epub 2018 Aug 21. Review.

PMID:
30131322
22.

Circulating plasma phospholipid fatty acids and risk of pancreatic cancer in a large European cohort.

Matejcic M, Lesueur F, Biessy C, Renault AL, Mebirouk N, Yammine S, Keski-Rahkonen P, Li K, Hémon B, Weiderpass E, Rebours V, Boutron-Ruault MC, Carbonnel F, Kaaks R, Katzke V, Kuhn T, Boeing H, Trichopoulou A, Palli D, Agnoli C, Panico S, Tumino R, Sacerdote C, Quirós JR, Duell EJ, Porta M, Sánchez MJ, Chirlaque MD, Barricarte A, Amiano P, Ye W, Peeters PH, Khaw KT, Perez-Cornago A, Key TJ, Bueno-de-Mesquita HB, Riboli E, Vineis P, Romieu I, Gunter MJ, Chajès V.

Int J Cancer. 2018 Nov 15;143(10):2437-2448. doi: 10.1002/ijc.31797. Epub 2018 Sep 21.

23.

Patient, Procedure, and Endoscopist Risk Factors for Perforation, Bleeding, and Splenic Injury After Colonoscopies.

Laanani M, Coste J, Blotière PO, Carbonnel F, Weill A.

Clin Gastroenterol Hepatol. 2019 Mar;17(4):719-727.e13. doi: 10.1016/j.cgh.2018.08.005. Epub 2018 Aug 9.

24.

Drug-induced coma after chemotherapy in intensive care unit: How to make the right diagnosis?

Boilève A, Osman D, Marthey L, Carbonnel F, Jozwiak M.

J Neurol Sci. 2018 Sep 15;392:137-138. doi: 10.1016/j.jns.2018.07.015. Epub 2018 Jul 21. No abstract available.

PMID:
30059846
25.

Heterogeneity of Colorectal Cancer Risk Factors by Anatomical Subsite in 10 European Countries: A Multinational Cohort Study.

Murphy N, Ward HA, Jenab M, Rothwell JA, Boutron-Ruault MC, Carbonnel F, Kvaskoff M, Kaaks R, Kühn T, Boeing H, Aleksandrova K, Weiderpass E, Skeie G, Borch KB, Tjønneland A, Kyrø C, Overvad K, Dahm CC, Jakszyn P, Sánchez MJ, Gil L, Huerta JM, Barricarte A, Quirós JR, Khaw KT, Wareham N, Bradbury KE, Trichopoulou A, La Vecchia C, Karakatsani A, Palli D, Grioni S, Tumino R, Fasanelli F, Panico S, Bueno-de-Mesquita B, Peeters PH, Gylling B, Myte R, Jirström K, Berntsson J, Xue X, Riboli E, Cross AJ, Gunter MJ.

Clin Gastroenterol Hepatol. 2019 Jun;17(7):1323-1331.e6. doi: 10.1016/j.cgh.2018.07.030. Epub 2018 Jul 26.

26.

Management of toxicities from immunotherapy: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up.

Haanen JBAG, Carbonnel F, Robert C, Kerr KM, Peters S, Larkin J, Jordan K; ESMO Guidelines Committee.

Ann Oncol. 2018 Oct 1;29(Suppl 4):iv264-iv266. doi: 10.1093/annonc/mdy162. No abstract available.

PMID:
29917046
27.

Dietary intake of total polyphenol and polyphenol classes and the risk of colorectal cancer in the European Prospective Investigation into Cancer and Nutrition (EPIC) cohort.

Zamora-Ros R, Cayssials V, Jenab M, Rothwell JA, Fedirko V, Aleksandrova K, Tjønneland A, Kyrø C, Overvad K, Boutron-Ruault MC, Carbonnel F, Mahamat-Saleh Y, Kaaks R, Kühn T, Boeing H, Trichopoulou A, Valanou E, Vasilopoulou E, Masala G, Pala V, Panico S, Tumino R, Ricceri F, Weiderpass E, Lukic M, Sandanger TM, Lasheras C, Agudo A, Sánchez MJ, Amiano P, Navarro C, Ardanaz E, Sonestedt E, Ohlsson B, Nilsson LM, Rutegård M, Bueno-de-Mesquita B, Peeters PH, Khaw KT, Wareham NJ, Bradbury K, Freisling H, Romieu I, Cross AJ, Vineis P, Scalbert A.

Eur J Epidemiol. 2018 Nov;33(11):1063-1075. doi: 10.1007/s10654-018-0408-6. Epub 2018 May 15.

28.

A prospective evaluation of plasma polyphenol levels and colon cancer risk.

Murphy N, Achaintre D, Zamora-Ros R, Jenab M, Boutron-Ruault MC, Carbonnel F, Savoye I, Kaaks R, Kühn T, Boeing H, Aleksandrova K, Tjønneland A, Kyrø C, Overvad K, Quirós JR, Sánchez MJ, Altzibar JM, María Huerta J, Barricarte A, Khaw KT, Bradbury KE, Perez-Cornago A, Trichopoulou A, Karakatsani A, Peppa E, Palli D, Grioni S, Tumino R, Sacerdote C, Panico S, Bueno-de-Mesquita HBA, Peeters PH, Rutegård M, Johansson I, Freisling H, Noh H, Cross AJ, Vineis P, Tsilidis K, Gunter MJ, Scalbert A.

Int J Cancer. 2018 Oct 1;143(7):1620-1631. doi: 10.1002/ijc.31563. Epub 2018 Jun 11.

29.

Risk of Serious and Opportunistic Infections Associated With Treatment of Inflammatory Bowel Diseases.

Kirchgesner J, Lemaitre M, Carrat F, Zureik M, Carbonnel F, Dray-Spira R.

Gastroenterology. 2018 Aug;155(2):337-346.e10. doi: 10.1053/j.gastro.2018.04.012. Epub 2018 Apr 12.

PMID:
29655835
30.

Prediagnostic Serum Vitamin D Levels and the Risk of Crohn's Disease and Ulcerative Colitis in European Populations: A Nested Case-Control Study.

Opstelten JL, Chan SSM, Hart AR, van Schaik FDM, Siersema PD, Lentjes EGWM, Khaw KT, Luben R, Key TJ, Boeing H, Bergmann MM, Overvad K, Palli D, Masala G, Racine A, Carbonnel F, Boutron-Ruault MC, Tjønneland A, Olsen A, Andersen V, Kaaks R, Kühn T, Tumino R, Trichopoulou A, Peeters PHM, Verschuren WMM, Witteman BJM, Oldenburg B.

Inflamm Bowel Dis. 2018 Feb 15;24(3):633-640. doi: 10.1093/ibd/izx050.

PMID:
29462382
31.

Prospective evaluation of antibody response to Streptococcus gallolyticus and risk of colorectal cancer.

Butt J, Jenab M, Willhauck-Fleckenstein M, Michel A, Pawlita M, Kyrø C, Tjønneland A, Boutron-Ruault MC, Carbonnel F, Severi G, Kaaks R, Kühn T, Boeing H, Trichopoulou A, la Vecchia C, Karakatsani A, Panico S, Tumino R, Agnoli C, Palli D, Sacerdote C, Bueno-de-Mesquita HBA, Weiderpass E, Sánchez MJ, Bonet Bonet C, Huerta JM, Ardanaz E, Bradbury K, Gunter M, Murphy N, Freisling H, Riboli E, Tsilidis K, Aune D, Waterboer T, Hughes DJ.

Int J Cancer. 2018 Jul 15;143(2):245-252. doi: 10.1002/ijc.31283. Epub 2018 Feb 14.

32.

Fibre intake and the development of inflammatory bowel disease: A European prospective multi-centre cohort study (EPIC-IBD).

Andersen V, Chan S, Luben R, Khaw KT, Olsen A, Tjonneland A, Kaaks R, Grip O, Bergmann MM, Boeing H, Hultdin J, Karling P, Overvad K, Oldenburg B, Opstelten J, Boutron-Ruault MC, Carbonnel F, Racine A, Key T, Masala G, Palli D, Tumino R, Trichopoulou A, Riboli E, Hart A.

J Crohns Colitis. 2018 Jan 24;12(2):129-136. doi: 10.1093/ecco-jcc/jjx136.

33.

Iron Supplementation-Induced Phosphaturic Osteomalacia: FGF23 is the Culprit.

Urbina T, Belkhir R, Rossi G, Carbonnel F, Pavy S, Collins M, Mariette X, Seror R.

J Bone Miner Res. 2018 Mar;33(3):540-542. doi: 10.1002/jbmr.3369. Epub 2018 Feb 7. No abstract available.

34.

Connected Health Devices for Health Care in French General Medicine Practice: Cross-Sectional Study.

El Amrani L, Oude Engberink A, Ninot G, Hayot M, Carbonnel F.

JMIR Mhealth Uhealth. 2017 Dec 21;5(12):e193. doi: 10.2196/mhealth.7427.

35.

Significance of Immune-related Lipase Increase Induced by Antiprogrammed Death-1 or Death Ligand-1 Antibodies: A Brief Communication.

Michot JM, Ragou P, Carbonnel F, Champiat S, Voisin AL, Mateus C, Lambotte O, Annereau M.

J Immunother. 2018 Feb/Mar;41(2):84-85. doi: 10.1097/CJI.0000000000000202.

PMID:
29252914
36.

Association Between Use of Thiopurines or Tumor Necrosis Factor Antagonists Alone or in Combination and Risk of Lymphoma in Patients With Inflammatory Bowel Disease.

Lemaitre M, Kirchgesner J, Rudnichi A, Carrat F, Zureik M, Carbonnel F, Dray-Spira R.

JAMA. 2017 Nov 7;318(17):1679-1686. doi: 10.1001/jama.2017.16071.

37.

Corrigendum: Third European Evidence-based Consensus on Diagnosis and Management of Ulcerative Colitis. Part 2: Current Management.

Harbord M, Eliakim R, Bettenworth D, Karmiris K, Katsanos K, Kopylov U, Kucharzik T, Molnár T, Raine T, Sebastian S, de Sousa HT, Dignass A, Carbonnel F; European Crohn’s and Colitis Organisation [ECCO].

J Crohns Colitis. 2017 Dec 4;11(12):1512. doi: 10.1093/ecco-jcc/jjx105. No abstract available.

PMID:
29088340
38.

Inflammatory gastrointestinal diseases associated with PD-1 blockade antibodies.

Collins M, Michot JM, Danlos FX, Mussini C, Soularue E, Mateus C, Loirat D, Buisson A, Rosa I, Lambotte O, Laghouati S, Chaput N, Coutzac C, Voisin AL, Soria JC, Marabelle A, Champiat S, Robert C, Carbonnel F.

Ann Oncol. 2017 Nov 1;28(11):2860-2865. doi: 10.1093/annonc/mdx403.

PMID:
29045560
39.

Raising Awareness About Cervical Cancer Using Twitter: Content Analysis of the 2015 #SmearForSmear Campaign.

Lenoir P, Moulahi B, Azé J, Bringay S, Mercier G, Carbonnel F.

J Med Internet Res. 2017 Oct 16;19(10):e344. doi: 10.2196/jmir.8421.

40.

Colon Immune-Related Adverse Events: Anti-CTLA-4 and Anti-PD-1 Blockade Induce Distinct Immunopathological Entities.

Coutzac C, Adam J, Soularue E, Collins M, Racine A, Mussini C, Boselli L, Kamsukom N, Mateus C, Charrier M, Cassard L, Planchard D, Ribrag V, Fizazi K, Loriot Y, Lepage P, Scoazec JY, Robert C, Carbonnel F, Chaput N.

J Crohns Colitis. 2017 Oct 1;11(10):1238-1246. doi: 10.1093/ecco-jcc/jjx081.

PMID:
28967957
41.

Long-term efficacy and safety of rituximab in IgG4-related disease: Data from a French nationwide study of thirty-three patients.

Ebbo M, Grados A, Samson M, Groh M, Loundou A, Rigolet A, Terrier B, Guillaud C, Carra-Dallière C, Renou F, Pozdzik A, Labauge P, Palat S, Berthelot JM, Pennaforte JL, Wynckel A, Lebas C, Le Gouellec N, Quémeneur T, Dahan K, Carbonnel F, Leroux G, Perlat A, Mathian A, Cacoub P, Hachulla E, Costedoat-Chalumeau N, Harlé JR, Schleinitz N.

PLoS One. 2017 Sep 15;12(9):e0183844. doi: 10.1371/journal.pone.0183844. eCollection 2017.

42.

Management of toxicities from immunotherapy: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up.

Haanen JBAG, Carbonnel F, Robert C, Kerr KM, Peters S, Larkin J, Jordan K; ESMO Guidelines Committee.

Ann Oncol. 2017 Jul 1;28(suppl_4):iv119-iv142. doi: 10.1093/annonc/mdx225. No abstract available. Erratum in: Ann Oncol. 2018 Oct 1;29(Suppl 4):iv264-iv266.

PMID:
28881921
43.

Dietary Polyphenols in the Aetiology of Crohn's Disease and Ulcerative Colitis-A Multicenter European Prospective Cohort Study (EPIC).

Lu Y, Zamora-Ros R, Chan S, Cross AJ, Ward H, Jakszyn P, Luben R, Opstelten JL, Oldenburg B, Hallmans G, Karling P, Grip O, Key T, Bergmann MM, Boeing H, Overvad K, Palli D, Masala G, Khaw KT, Racine A, Carbonnel F, Boutron-Ruault MC, Andersen V, Olsen A, Tjonneland A, Kaaks R, Tumino R, Trichopoulou A, Scalbert A, Riboli E, Hart AR.

Inflamm Bowel Dis. 2017 Dec;23(12):2072-2082. doi: 10.1097/MIB.0000000000001108.

44.

Diet and Risk of Cholecystectomy: A Prospective Study Based on the French E3N Cohort.

Barré A, Gusto G, Cadeau C, Carbonnel F, Boutron-Ruault MC.

Am J Gastroenterol. 2017 Sep;112(9):1448-1456. doi: 10.1038/ajg.2017.216. Epub 2017 Jul 25.

PMID:
28741614
45.

Letter: sprue-like enteropathy associated with angiotensin II receptor blockers other than olmesartan-authors'reply.

Marthey L, Carbonnel F.

Aliment Pharmacol Ther. 2017 Aug;46(4):473-474. doi: 10.1111/apt.14191. No abstract available.

46.

Impact of Infliximab and Cyclosporine on the Risk of Colectomy in Hospitalized Patients with Ulcerative Colitis Complicated by Cytomegalovirus-A Multicenter Retrospective Study.

Kopylov U, Papamichael K, Katsanos K, Waterman M, Bar-Gil Shitrit A, Boysen T, Portela F, Peixoto A, Szilagyi A, Silva M, Maconi G, Har-Noy O, Bossuyt P, Mantzaris G, Barreiro de Acosta M, Chaparro M, Christodoulou DK, Eliakim R, Rahier JF, Magro F, Drobne D, Ferrante M, Sonnenberg E, Siegmund B, Muls V, Thurm T, Yanai H, Dotan I, Raine T, Levin A, Israeli E, Ghalim F, Carbonnel F, Vermeire S, Ben-Horin S, Roblin X.

Inflamm Bowel Dis. 2017 Sep;23(9):1605-1613. doi: 10.1097/MIB.0000000000001160.

PMID:
28590343
47.

Genetic variation in the ADIPOQ gene, adiponectin concentrations and risk of colorectal cancer: a Mendelian Randomization analysis using data from three large cohort studies.

Nimptsch K, Song M, Aleksandrova K, Katsoulis M, Freisling H, Jenab M, Gunter MJ, Tsilidis KK, Weiderpass E, Bueno-De-Mesquita HB, Chong DQ, Jensen MK, Wu C, Overvad K, Kühn T, Barrdahl M, Melander O, Jirström K, Peeters PH, Sieri S, Panico S, Cross AJ, Riboli E, Van Guelpen B, Myte R, Huerta JM, Rodriguez-Barranco M, Quirós JR, Dorronsoro M, Tjønneland A, Olsen A, Travis R, Boutron-Ruault MC, Carbonnel F, Severi G, Bonet C, Palli D, Janke J, Lee YA, Boeing H, Giovannucci EL, Ogino S, Fuchs CS, Rimm E, Wu K, Chan AT, Pischon T.

Eur J Epidemiol. 2017 May;32(5):419-430. doi: 10.1007/s10654-017-0262-y. Epub 2017 May 26.

48.

Characterization of CD4 T Cell Epitopes of Infliximab and Rituximab Identified from Healthy Donors.

Hamze M, Meunier S, Karle A, Gdoura A, Goudet A, Szely N, Pallardy M, Carbonnel F, Spindeldreher S, Mariette X, Miceli-Richard C, Maillère B.

Front Immunol. 2017 May 5;8:500. doi: 10.3389/fimmu.2017.00500. eCollection 2017.

49.

Incidence, Phenotype, and Mortality of Inflammatory Bowel Disease 'Twenty Years After'.

Carbonnel F, Boutron MC.

J Crohns Colitis. 2017 Oct 1;11(10):1159-1160. doi: 10.1093/ecco-jcc/jjx072. No abstract available.

PMID:
28525593
50.

Third European Evidence-based Consensus on Diagnosis and Management of Ulcerative Colitis. Part 2: Current Management.

Harbord M, Eliakim R, Bettenworth D, Karmiris K, Katsanos K, Kopylov U, Kucharzik T, Molnár T, Raine T, Sebastian S, de Sousa HT, Dignass A, Carbonnel F; European Crohn’s and Colitis Organisation [ECCO].

J Crohns Colitis. 2017 Jul 1;11(7):769-784. doi: 10.1093/ecco-jcc/jjx009. No abstract available. Erratum in: J Crohns Colitis. 2017 Dec 4;11(12):1512.

PMID:
28513805

Supplemental Content

Loading ...
Support Center